期刊文献+

离子敏感型左氧氟沙星原位胶化滴眼液的制备及质量控制 被引量:3

Preparation and Quality Control of Ion-Activated in Situ Gelling of Levofloxacin Hydrochloride Eye Drops
下载PDF
导出
摘要 目的制备左氧氟沙星原位胶化滴眼剂并建立其质量控制方法。方法以氯化钠为渗透压调节剂、海藻酸钠为增稠剂、羟苯乙酯为防腐剂,制备左氧氟沙星原位胶化滴眼剂,用高效液相色谱法测定含量。结果制得的液体为无色或浅黄色澄明液体,pH为5.57,鉴别、检查结果均符合2005年版《中国药典(二部)》中的相关规定,含量测定的线性范围为9.39~62.60μg/mL,平均回收率为99.27%,RSD为2.92%(n=6)。结论左氧氟沙星原位胶化滴眼液处方合理,质量符合要求。 Objective To prepare insitu gelling of Levofloxacin Hydrochloride Eye Drops and to establish its quality control method. Methods The insitu gelling of Levofloxacin Hydrocbloride Eye Drops was prepared with sodium chloride as buffer to regulate the pH value and osmotic pressure and with sodium polymannuronate as thickener. The content of levofloxacin bydrochloride was determined by high performance liquid chromatography(HPLC). Results The sustained- release eye drops were colorless or yellow limpid liquid. Its test and identification results all conformed to the related stipulation stated in Chinese Pharmacopeia (2005 edition). There was the good linear relationship within the concentration range of 9.39- 62.60 μg/mL for levofloxacin hydrochloride, and its average recovery rate was 99.27%, RSD was 2.92% and pH was 5.57. Conclusion The preparative method is simple and feasible. The quality of insitu gelling of Hydrochloride Levofloxacin Eye Drops is stable and controllable.
出处 《中国药业》 CAS 2010年第7期38-39,共2页 China Pharmaceuticals
关键词 左氧氟沙星 原位胶化 滴眼剂 质量控制 levofloxacin insitu gelling eye drops quality control
  • 相关文献

参考文献6

二级参考文献51

  • 1李琦,王凤山,凌沛学,张天民.玻璃酸作为药物媒介在医药研发中的应用[J].中国药学杂志,2005,40(7):485-488. 被引量:5
  • 2周远大,何海霞,雷自强,朱治本,杨淑群,李远宗.环丙沙星滴眼剂在家兔眼内组织分布及其药物动力学[J].中国医院药学杂志,1997,17(1):6-7. 被引量:4
  • 3Cohen S, Lobel E, Trevgoda A, et al. A novel in situ-forming ophthalmic drug delivery systems from alginates undergoing gelation in the eye [J] .J Controlled Release, 1997,44(2-3) :201.
  • 4Gurny R, Boye T, lbrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery [J ]. J Controlled Release, 1985,2(3 ): 353.
  • 5Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system [ J ]. J Controlled Release ,2001,73(2) :205.
  • 6Lin HR, Sung KC. Carbopol/pluronic phase change solutions for ophthalmic drug delivery [J ]. J Controlled Release ,2000,69(3 ) :379.
  • 7Yun MO,Choi HG,Jung JH,et al. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement [J]. Int J Pharm, 1999,189(2) : 137.
  • 8Desai SD,Blanchard J. Evaluation of Pluronic F127 sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model [J ]. J Pharm Sci, 1998,87(10) : 1190.
  • 9Shin SC, Cho CW, Oh IJ. Effect of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins [J]. Int J Pharm ,2001,222(2) : 199.
  • 10Wei G, Xu H, Ding PT, et al. Thermosetting gels with modulated gelation temperature for ophthalmic use: rheological and gamma scintigraphic studies [ J ]. J Controlled Release, 2002,83 ( 1 ) : 65.

共引文献224

同被引文献17

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部